Putnam Investments’s bluebird bio BLUE Stock Holding History

Putnam Investments’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13,055	Closed	-$1.27M	–	1135
2022 Q1	$1.27M	Buy	13,055 +2,278	+21%	+$301K	﹤0.01%	878
2021 Q4	$2.15M	Buy	+10,777	New	+$2.54M	﹤0.01%	751
2020 Q1	–	Sell	-646	Closed	-$734K	–	836
2019 Q4	$734K	Hold	646	–	–	﹤0.01%	771
2019 Q3	$768K	Sell	646 -645	-50%	-$985K	﹤0.01%	779
2019 Q2	$2.13M	Buy	1,291 +295	+30%	+$510K	﹤0.01%	716
2019 Q1	$2.03M	Sell	996 -4,692	-82%	-$8.26M	﹤0.01%	691
2018 Q4	$7.31M	Hold	5,688	–	–	0.02%	385
2018 Q3	$10.8M	Sell	5,688 -716	-11%	-$1.48M	0.02%	378
2018 Q2	$13M	Sell	6,404 -5,660	-47%	-$12.9M	0.03%	324
2018 Q1	$26.7M	Buy	+12,064	New	+$30.7M	0.06%	227

Other funds holding BLUE

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Putnam Investments's BLUE Position: Q2 2022 in Review

Putnam Investments sold out of bluebird bio (BLUE) in Q2 2022, closing a stake of 13,055 shares — an estimated $1.27M sold.

Putnam Investments first reported a position in BLUE in Q1 2018 and held it in 10 quarters. The position peaked at $26.7M in Q1 2018. 151 funds tracked by Wall St. Rank hold BLUE as of Q2 2022.

Putnam Investments reported no remaining bluebird bio position as of Q2 2022 after selling out during the quarter.
Putnam Investments sold 13,055 bluebird bio shares in Q2 2022, an estimated $1.27M.
Putnam Investments first reported a position in bluebird bio in Q1 2018 and held it in 10 quarters.
Putnam Investments's bluebird bio position peaked at $26.7M in Q1 2018.
151 funds tracked by Wall St. Rank held bluebird bio as of Q2 2022.

Based on Putnam Investments's 13F filing for Q2 2022, filed 15 Aug 2022.